Alzheimer's drug may double as bone protector for seniors
NCT ID NCT06041789
First seen Nov 01, 2025 · Last updated Jun 18, 2026 · Updated 31 times
Summary
This study looks at whether donepezil, a drug already used for Alzheimer's, can improve bone health and lower fracture risk in older adults with mild to moderate Alzheimer's. About 45 participants will take either donepezil or memantine daily for 12 months. Researchers will measure bone density and blood markers of bone turnover to see if donepezil offers extra protection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Duke Memory Disorders Clinic
RECRUITINGDurham, North Carolina, 27705, United States
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.